The fast routes and the slow routes
Inhalation (flower, vaporizers): onset in 1–10 minutes, peak around 30, done in 2–4 hours. Best for symptoms that spike — breakthrough pain, nausea waves, panic-adjacent moments — because you can titrate puff by puff. The costs: lung irritation (smoke worse than dry-herb vaporization), smell, and the shortest duration of any route. Several medical-only states ban smokable flower entirely; check your state page.
Oral (edibles, capsules) runs 30–120 minutes to onset and 4–8+ hours of effect — the overnight and all-day workhorse for chronic pain and sleep, and the easiest to dose consistently once you know your number. The liver converts THC to a more potent metabolite, which is why edibles hit harder per milligram and why patient lore overflows with edible misadventure. Tinctures split the difference: sublingual absorption in 15–45 minutes, moderate duration, drop-level precision — arguably the most medically sensible starting format. Topicals act locally on joints and skin with little to no intoxication, useful for arthritis-type complaints; transdermal patches are the exception that does enter the bloodstream.
Matching method to symptom pattern
Chronic background symptoms with overnight needs (persistent pain, sleep maintenance): oral products dosed in the evening. Episodic symptoms (migraine onset, nausea, anxiety spikes): inhaled or sublingual for speed. Localized musculoskeletal pain: try topical first — lowest side-effect cost. Many established patients run a base-plus-breakthrough pattern, an edible floor with an inhaled rescue, exactly like long- and short-acting medication pairs elsewhere in medicine.
Lung-health honesty: no smoked product is health-neutral, and the National Academies links regular cannabis smoking to chronic bronchitis symptoms. Dry-herb vaporizers cut combustion byproducts substantially; oral routes eliminate the issue. After the 2019 EVALI outbreak (tied overwhelmingly to illicit vitamin-E-acetate cartridges), one rule stands: licensed, batch-tested vape products only.
The information on this site is for educational purposes only and is not medical or legal advice. Cannabis use carries risks; consult a licensed physician about whether medical cannabis is appropriate for you. Federal status (as of June 2026): marijuana dispensed under state medical licenses and FDA-approved cannabis products are Schedule III controlled substances; all other marijuana remains Schedule I under U.S. federal law. Laws cited here change; confirm current rules with the linked primary sources before acting on them.